Amin Hallihan

Delaware

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Cases24
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
BiotechChemicalTransport., E-Comm.
Top Attorneys
Patrick J. CoyneNeal S. CohenPeter Kinsella
Elite Ratings
DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
A

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered
Case
Description
09/06/23
Purdue Pharma LP v. Intellipharmaceutics Intl Inc
1:18-CV-00404
 (
D. DE
)
SO ORDERED Granting (D.I. 143 in 18-cv-404-RGA-SRF; D.I. 261 in 17-cv-392-RGA) Unopposed Motion for Extension of Time to Comply with Protective Order Deadlines. Signed by Judge Richard G. Andrews on 9/6/2023. Associated Cases: 1:17-cv-00392-RGA, 1:18-cv-00404-RGA-SRF(nms) (Entered: 09/06/2023)
09/01/23
Purdue Pharma LP v. Intellipharmaceutics Intl Inc
1:17-CV-00392
 (
D. DE
)
Unopposed Motion for Extension of Time to Protective Order Deadlines - filed by Purdue Pharma L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies, Grünenthal GmbH. (Dellinger, Megan) Modified on 9/5/2023 (nms). (Entered: 09/01/2023)
05/31/23
Glaxosmithkline LLC v. Glenmark Pharmaceuticals Inc
1:14-CV-00877
 (
D. DE
)
NOTICE requesting Clerk to remove William R. Woodford, Philip W. Goter and Craig E. Countryman as co-counsel. Reason for request: No longer at firm. (McCann, Douglas) (Entered: 05/31/2023)
05/31/23
Glaxosmithkline LLC v. Glenmark Pharmaceuticals Inc
1:14-CV-00877
 (
D. DE
)
NOTICE requesting Clerk to remove Elizabeth M. Flanagan as co-counsel. Reason for request: No longer working on case. (McCann, Douglas) (Entered: 05/31/2023)
05/31/23
Glaxosmithkline LLC v. Glenmark Pharmaceuticals Inc
1:14-CV-00877
 (
D. DE
)
NOTICE requesting Clerk to remove W. Chad Shear as co-counsel. Reason for request: No longer working on case. (McCann, Douglas) (Entered: 05/31/2023)
10/31/22
Biogen Intl GmbH v. Amneal Pharma LLC
1:17-CV-00823
 (
D. DE
)
USCA Order Terminating Appeal as to 410 Notice of Appeal (Federal Circuit) filed by Biogen International GmbH, Biogen MA Inc.. USCA Decision: Appeal Dismissed. (mdb) (Entered: 10/31/2022)
10/13/21
Bristol Myers Squibb Co v. Aurobindo Pharma USA Inc
1:17-CV-00374
 (
D. DE
)
MANDATE of USCA as to 742 Notice of Appeal (Federal Circuit) filed by Unichem Laboratories, Ltd., 740 Notice of Appeal (Federal Circuit) filed by Sigmapharm Laboratories LLC, 743 Notice of Appeal (Federal Circuit) filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd. (ntl) (Entered: 10/13/2021)
01/28/19
In re: Bendamustine Consolidated Cases
1:13-CV-02046
 (
D. DE
)
USCA Order Terminating Appeal as to 509 Notice of Cross Appeal filed by Cephalon Inc., 508 Notice of Appeal (Federal Circuit) filed by InnoPharma Inc.. USCA Decision: appeals are voluntarily dismissed. (mdb) (Entered: 01/28/2019)